DEVELOPING IN-HOUSE, POINT-OF-CARE MANUFACTURED ANTI-CD19 CHIMAERIC ANTIGEN RECEPTOR (CAR)-T CELLS

被引:0
|
作者
Chan, Nelson Chun Ngai [1 ,2 ]
Loaiza, Sandra [1 ,2 ]
Uddin, Shab [1 ,2 ]
Aina, Edward [1 ,2 ]
Cook, Lucy [3 ]
Palanicawandar, Renuka
Bara, Anna [4 ]
Olavarria, Eduardo [3 ]
Apperley, Jane [3 ]
Karadimitris, Anastasios [3 ]
机构
[1] Imperial Coll Healthcare NHS Trust, John Goldman Ctr Cellular Therapies, London, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Imperial Coll London, Ctr Haematol, London, England
[4] Natl Inst Hlth Res Imperial Clin Res Facil, London, England
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P085
引用
收藏
页码:209 / 210
页数:2
相关论文
共 50 条
  • [21] The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies
    Cao, Jun-Xia
    Gao, Wei-Jian
    You, Jia
    Wu, Li-Hua
    Liu, Jin-Long
    Wang, Zheng-Xu
    CYTOTHERAPY, 2019, 21 (07) : 769 - 781
  • [22] Development of Anti-CD19 Chimeric Antigen Receptor T-Cells with Immune Checkpoint Silencing
    Matthes, Thomas
    Roussel-Gervais, Audrey
    Salmon, Patrick
    Ilmjarv, Sten
    Sakic, Antonija
    Krause, Karl-Heinz
    Alessandrini, Marco
    MOLECULAR THERAPY, 2021, 29 (04) : 312 - 312
  • [23] Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
    Ambrose, Christine
    Su, Lihe
    Wu, Lan
    Dufort, Fay J.
    Sanford, Thomas
    Birt, Alyssa
    Hackel, Benjamin J.
    Hombach, Andreas
    Abken, Hinrich
    Lobb, Roy R.
    Rennert, Paul D.
    PLOS ONE, 2021, 16 (03):
  • [24] Autologous Anti-CD19 CAR T Cells as Therapy for Systemic Lupus Erythematosus
    Radic, Marko
    Randolph, Brion
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (01): : 3 - 4
  • [25] A Phase 1 Study with Point-of-Care Manufacturing of Dual Targeted, Tandem Anti-CD19, Anti-CD20 Chimeric Antigen Receptor Modified T (CART-T) Cells for Relapsed, Refractory, Non-Hodgkin Lymphoma
    Shah, Nirav N.
    Zhu, Fenlu
    Taylor, Carolyn
    Schneider, Dina
    Krueger, Winfried
    Worden, Andrew
    Yim, Sharon
    Fenske, Timothy S.
    Hamadani, Mehdi
    Johnson, Bryon
    Dropulic, Boro
    Orentas, Rimas
    Hari, Parameswaran
    BLOOD, 2018, 132
  • [26] Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
    Koh, Seung Kwon
    Kim, Hyojin
    Han, Bohwa
    Jo, Hantae
    Doh, Junsang
    Park, Jeehun
    Ha Nguyen, Minh
    Kim, Hyun-Young
    Kim, Haneul
    Lee, Seung-Hwan
    Kim, Chan Hyuk
    Cho, Duck
    BLOOD, 2025, 145 (09) : 956 - 969
  • [27] Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors
    Xia, Yuan
    Zhang, Jue
    Li, Jing
    Zhang, Lina
    Li, Jianyong
    Fan, Lei
    Chen, Lijuan
    ANNALS OF MEDICINE, 2022, 54 (01) : 2951 - 2965
  • [28] Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
    Castella, Maria
    Boronat, Anna
    Martin-Ibanez, Raquel
    Rodriguez, Vanina
    Sune, Guillermo
    Caballero, Miguel
    Marzal, Berta
    Perez-Amill, Lorena
    Martin-Antonio, Beatriz
    Castano, Julio
    Bueno, Clara
    Balague, Olga
    Azucena Gonzalez-Navarro, Europa
    Serra-Pages, Carles
    Engel, Pablo
    Vilella, Ramon
    Benitez-Ribas, Daniel
    Ortiz-Maldonado, Valentin
    Cid, Joan
    Tabera, Jaime
    Canals, Josep M.
    Lozano, Miquel
    Baumann, Tycho
    Vilarrodona, Anna
    Trias, Esteve
    Campo, Elias
    Menendez, Pablo
    Urbano-Ispizua, Alvaro
    Yague, Jordi
    Perez-Galan, Patricia
    Rives, Susana
    Delgado, Julio
    Juan, Manel
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 12 : 134 - 144
  • [29] Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma
    Li, Sujun
    Xue, Lei
    Wang, Min
    Qiang, Ping
    Xu, Hui
    Zhang, Xuhan
    Kang, Wenyao
    You, Fengtao
    Xu, Hanying
    Wang, Yu
    Liu, Xin
    Yang, Lin
    Wang, Xingbing
    ONCOTARGETS AND THERAPY, 2019, 12 : 5627 - 5638
  • [30] Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
    Rossi, John
    Paczkowski, Patrick
    Shen, Yueh-Wei
    Morse, Kevin
    Flynn, Brianna
    Kaiser, Alaina
    Ng, Colin
    Gallatin, Kyle
    Cain, Tom
    Fan, Rong
    Mackay, Sean
    Heath, James R.
    Rosenberg, Steven A.
    Kochenderfer, James N.
    Zhou, Jing
    Bot, Adrian
    BLOOD, 2018, 132 (08) : 804 - 814